EcoDrugPlus

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSEBUG00000006160
Gene Symbol: PSMA1
1 Cross references
285 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSEBUG00000009779
Gene Symbol: PSMA3
1 Cross references
252 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSEBUG00000009681
Gene Symbol: PSMA4
1 Cross references
254 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSEBUG00000014540
Gene Symbol: PSMA5
1 Cross references
212 Possible Orthologues:

Proteasome 20s Subunit Alpha 6a

Ensembl ID : ENSEBUG00000009581
Gene Symbol: PSMA6A
1 Cross references
333 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSEBUG00000011772
Gene Symbol: PSMA8
1 Cross references
205 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSEBUG00000003225
Gene Symbol: PSMB1
1 Cross references
219 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSEBUG00000006620
Gene Symbol: PSMB1
1 Cross references
219 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSEBUG00000013966
Gene Symbol: PSMB2
1 Cross references
223 Possible Orthologues:

Proteasome 20s Subunit Beta 3

Ensembl ID : ENSEBUG00000016297
Gene Symbol: PSMB3
1 Cross references
261 Possible Orthologues:

Proteasome 20s Subunit Beta 4

Ensembl ID : ENSEBUG00000002487
Gene Symbol: PSMB4
1 Cross references
215 Possible Orthologues:

Proteasome 20s Subunit Beta 6

Ensembl ID : ENSEBUG00000013943
Gene Symbol: PSMB6
1 Cross references
235 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).